Melovem

Authorised

This medicine is authorised for use in the European Union

meloxicam

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Melovem : EPAR - Summary for the public

Product information

Melovem : EPAR - Product Information

Melovem : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Melovem
• Active substance:
  meloxicam
• International non-proprietary name (INN) or common name:
  meloxicam

Pharmacotherapeutic group

Oxicams

Authorisation details

• EMA product number:
  EMEA/V/C/000152
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Assessment history

Changes since initial authorisation of medicine

Melovem : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Melovem (VRA-0015)

AdoptedReference Number: EMA/CVMP/80399/2023

Melovem-V-C-152-X-03 : EPAR - Assessment Report - Extension

Adopted

Melovem-V-C-152-X-04 : EPAR - Assessment Report - Extension

Adopted

CVMP post-authorisation summary of positive opinion for Melovem

AdoptedReference Number: EMA/CVMP/384391/2013

CVMP post-authorisation summary of positive opinion for Melovem

AdoptedReference Number: EMA/CVMP/384390/2013

Initial marketing authorisation documents

CVMP summary of opinion for Melovem

AdoptedReference Number: EMEA/CVMP/247920/2009

Melovem : EPAR - Procedural steps taken before authorisation

Melovem : EPAR - Scientific Discussion